Sustainable drug plans: it takes a village
Vice President and Chief Operating Officer
Director of Payor Solutions
The high cost of drug plans is perhaps the number one acknowledged challenge for Canadian plan sponsors, most of which are employers that deliver drug benefit coverage to nearly half the population. In one survey, 66% of plan sponsors reported that their total benefit costs increased over the past three years, and 80% are concerned that growing costs will exceed the rate of inflation during the next three to five years.
While redesigned drug plans and policy reforms at both Federal and Provincial levels can go a long way to resolving the pain many Canadians experience in getting access to much needed medications, these measures alone are not enough.